Pharmaceuticals

Calcitonin Injection Market Outlook Emphasizing Demand Growth from 2026–2030

March 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Calcitonin Injection Market During The Forecast Period 2026–2030?

The calcitonin injection market size has demonstrated significant expansion in recent years. This market is projected to increase from $0.73 billion in 2025 to $0.79 billion in 2026, progressing at a compound annual growth rate (CAGR) of 8.4%. The factors contributing to its historical growth include osteoporosis prevalence, hospital injectable therapies, fracture management protocols, calcium metabolism disorders, and the aging population.

The calcitonin injection market is anticipated to show significant expansion over the next few years. It is projected to reach $1.07 billion by 2030, with a compound annual growth rate (CAGR) of 8.1%. The expected growth during this period can be ascribed to an aging global population, increased demand for injectable treatments, heightened awareness of bone diseases, progress in synthetic peptide development, and the broadening of specialty care services. Prominent trends for the forecast period encompass ongoing utilization in osteoporosis management, the expansion of injectable bone therapies, wider availability of hypercalcemia treatments, a focused approach on geriatric bone health, and a transition toward synthetic calcitonin.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24490&type=smp

What Underlying Factors Are Accelerating The Growth Of The Calcitonin Injection Market?

The growing incidence of osteoporosis is anticipated to fuel the expansion of the calcitonin injection market in the future. This condition, osteoporosis, is defined by reduced bone density and a heightened risk of fractures, predominantly observed in older adults, particularly postmenopausal women. The rise in osteoporosis cases is linked to an aging population, where extended life expectancies naturally contribute to bone density loss and elevate disease susceptibility. Calcitonin injections are instrumental in managing osteoporosis by regulating calcium levels and decelerating bone loss, thus effectively preserving bone density. These injections offer a precise treatment via simple administration, enhancing patient adherence and diminishing fracture risks. As an illustration, Healthy Bones Australia, a non-profit organization in Australia dedicated to osteoporosis prevention and bone health, reported in August 2024 that approximately 6.2 million Australians aged 50 and above, accounting for about 67 percent of this demographic, experienced poor bone health in 2023, with around 23 percent of these individuals diagnosed with osteoporosis. Consequently, the rising prevalence of osteoporosis is a significant catalyst for the calcitonin injection market’s growth. The broadening availability of home healthcare services is anticipated to stimulate the expansion of the calcitonin injection market in the coming years. Home healthcare encompasses medical and supportive care provided to patients in their residences by qualified healthcare professionals. The growth of these services is driven by a rising trend of patients transitioning from hospital settings to receiving care at home, which aids in lowering overall treatment expenses while enhancing patient comfort and access. The calcitonin injection market is experiencing heightened demand as the swift increase in home healthcare services prompts providers to embrace injectable treatments that facilitate the at-home management of conditions such as osteoporosis and acute pain. For example, the National Association for Home Care and Hospice, a US-based non-profit organization advocating for chronically ill, disabled, and dying US citizens, reported in February 2023 that roughly 12 million Americans receive some form of home healthcare annually, with this figure projected to rise further. Thus, the growth in home healthcare services is a key factor propelling the calcitonin injection market.

What Market Segments Are Evaluated Within The Calcitonin Injection Market?

The calcitonin injection market covered in this report is segmented –

1) By Type Of Calcitonin: Salmon Calcitonin, Human Calcitonin, Synthetic Calcitonin

2) By Route Of Administration: Intravenous (IV) Injection, Subcutaneous Injection, Intramuscular Injection

3) By Distribution Channel: Direct Sales, Online Pharmacy, Retail Pharmacy, Healthcare Institutions

4) By Therapeutic Application: Osteoporosis Treatment, Pagets Disease Management, Hypercalcemia Control, Bone Metastases Therapy

5) By End-User: Hospitals, Specialty Clinics, Geriatric Care Facilities, Home Healthcare

Subsegments:

1) By Salmon Calcitonin, Synthetic Salmon Calcitonin, Recombinant Salmon Calcitonin

2) By Human Calcitonin, Recombinant Human Calcitonin, Synthetic Human Calcitonin

3) By Synthetic Calcitonin, Peptide-Based Synthetic Calcitonin, Analog Synthetic Calcitonin

What Industry Trends Are Redefining The Calcitonin Injection Market?

Major companies operating in the calcitonin injection market are focusing on developing innovative products, such as USP synthetic injections, to enhance treatment effectiveness and improve patient outcomes. USP Synthetic Injections are injectable medications that contain synthetically produced active ingredients that meet the strict quality, purity, strength, and identity standards set by the United States Pharmacopeia (USP). These injections are manufactured under regulated conditions to ensure they are safe and effective for therapeutic use. For instance, in February 2025, Fresenius Kabi, a Germany-based pharmaceutical company, launched calcitonin salmon injection, a USP synthetic, to treat symptomatic Paget’s disease of the bone and hypercalcemia. It is a sterile solution formulated for intramuscular or subcutaneous injection, available in a strength of 200 USP units per mL and packaged in a 2 mL multi-dose vial containing 400 USP units. It should be stored refrigerated between 2°C and 8°C. This injectable medication acts as a calcium regulator. It is indicated for the treatment of symptomatic Paget’s disease of bone when alternative treatments are unsuitable, hypercalcemia, and postmenopausal osteoporosis when other options are not appropriate.

Who Are The Top Market Participants Influencing The Calcitonin Injection Market?

Major companies operating in the calcitonin injection market are Pfizer Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Lupin Limited, Aurobindo Pharma Limited, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, Alembic Pharmaceuticals Limited, Alkem Laboratories Limited, Intas Pharmaceuticals Limited, Emcure Pharmaceuticals Limited, Wockhardt Limited, Accord Healthcare Ltd., Sandoz International GmbH, Amneal Pharmaceuticals LLC, Apotex Inc., Mylan N.V., Cadila Pharmaceuticals Limited, Macleods Pharmaceuticals Ltd., Bharat Parenterals Limited

Read the full calcitonin injection market report here:

https://www.thebusinessresearchcompany.com/report/calcitonin-injection-global-market-report

Which Region Is Projected To Dominate The Calcitonin Injection Market During The Forecast Period?

North America was the largest region in the calcitonin injection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the calcitonin injection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Calcitonin Injection Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24490&type=smp

Browse Through More Reports Similar to the Global Calcitonin Injection Market 2026, By The Business Research Company

Companion Animal Pharmaceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/companion-animal-pharmaceuticals-global-market-report

Pharmaceutical Excipient Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

Pharmaceutical Drug Delivery Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795